Resultats de la cerca - Michael A. Carducci

Refinar resultats
  1. 1
    Novel targeted therapeutics for metastatic castration-resistant prostate cancer

    Novel targeted therapeutics for metastatic castration-resistant prostate cancer per Emmanuel S. Antonarakis, Michael A. Carducci, Mario A. Eisenberger

    Publicat 2009
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Use of androgen deprivation therapy in prostate cancer: indications and prevalence

    Use of androgen deprivation therapy in prostate cancer: indications and prevalence per Roisín M. Connolly, Michael A. Carducci, Emmanuel S. Antonarakis

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation

    The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation per Jill Gilbert, Steve Gore, James G. Herman, Michael A. Carducci

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Contemporary experience with ketoconazole in patients with metastatic castration‐resistant prostate cancer: Clinical factors associated with PSA response and disease progression

    Contemporary experience with ketoconazole in patients with metastatic castration‐resistant prostate cancer: Clinical factors associated with PSA response and disease progression per Daniel Keizman, Peng Huang, Michael A. Carducci, Mario A. Eisenberger

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Changes in PSA kinetics predict metastasis‐free survival in men with PSA‐recurrent prostate cancer treated with nonhormonal agents

    Changes in PSA kinetics predict metastasis‐free survival in men with PSA‐recurrent prostate cancer treated with nonhormonal agents per Emmanuel S. Antonarakis, Marianna Zahurak, Jianqing Lin, Daniel Keizman, Michael A. Carducci, Mario A. Eisenberger

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

    Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer per Ryan M. Franke, Michael A. Carducci, Michelle A. Rudek, Sharyn D. Baker, Alex Sparreboom

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Effects of a Problem-Solving Intervention (COPE) on Quality of Life for Patients with Advanced Cancer on Clinical Trials and their Caregivers: Simultaneous Care Educational Intervention (SCEI): Linking Palliation and Clinical Trials

    Effects of a Problem-Solving Intervention (COPE) on Quality of Life for Patients with Advanced Cancer on Clinical Trials and their Caregivers: Simultaneous Care Educational Interve... per Frederick J. Meyers, Michael A. Carducci, Matthew Loscalzo, John Linder, Tamara A. Greasby, Laurel Beckett

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer

    The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer per Michael T. Schweizer, Xian Zhou, Hao Wang, Sunakshi Bassi, Michael A. Carducci, Mario A. Eisenberger, Emmanuel S. Antonarakis

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Association of pretreatment neutrophil‐to‐lymphocyte ratio (<scp>NLR</scp>) and overall survival (<scp>OS</scp>) in patients with metastatic castration‐resistant prostate cancer (<scp>mCRPC</scp>) treated with first‐line docetaxel

    Association of pretreatment neutrophil‐to‐lymphocyte ratio (<scp>NLR</scp>) and overall survival (<scp>OS</scp>) in patients with metastatic castration‐resistant prostate cancer (<... per Philipp Nuhn, Ajay Vaghasia, Jatinder Goyal, Xian Zhou, Michael A. Carducci, Mario A. Eisenberger, Emmanuel S. Antonarakis

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Feasibility and value of PatientViewpoint: a web system for patient‐reported outcomes assessment in clinical practice

    Feasibility and value of PatientViewpoint: a web system for patient‐reported outcomes assessment in clinical practice per Claire Snyder, Amanda L. Blackford, Antonio C. Wolff, Michael A. Carducci, Joseph M. Herman, Albert W. Wu

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Long‐term effects of androgen deprivation therapy in prostate cancer patients

    Long‐term effects of androgen deprivation therapy in prostate cancer patients per Shehzad Basaria, John Lieb, Alice Tang, Theodore L. DeWeese, Michael A. Carducci, Mario A. Eisenberger, Adrian S. Dobs

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy

    Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy per Milena Braga‐Basaria, Adrian S. Dobs, Denis C. Muller, Michael A. Carducci, Majnu John, Josephine M. Egan, Shehzad Basaria

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

    The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic... per Daniel Keizman, Maya Ish‐Shalom, Peng Huang, Mario A. Eisenberger, Роберто Пили, Hans J. Hammers, Michael A. Carducci

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer

    American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resist... per Ethan Basch, Mark R. Somerfield, Tomasz M. Beer, Michael A. Carducci, Celestia S. Higano, Maha Hussain, Howard I. Scher

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Can Patient-Reported Outcome Measures Identify Cancer Patients' Most Bothersome Issues?

    Can Patient-Reported Outcome Measures Identify Cancer Patients' Most Bothersome Issues? per Claire Snyder, Amanda L. Blackford, Neil K. Aaronson, Symone Detmar, Michael A. Carducci, Michael Brundage, Albert W. Wu

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician’s attention

    Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician’s attention per Claire Snyder, Amanda L. Blackford, Toru Okuyama, Tatsuo Akechi, Hiroko Yamashita, Tatsuya Toyama, Michael A. Carducci, Albert W. Wu

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients’ supportive care needs

    Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients’ supportive care needs per Claire Snyder, Amanda L. Blackford, Jonathan Sussman, Daryl Bainbridge, Doris Howell, Hsien Seow, Michael A. Carducci, Albert W. Wu

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth <i>In vitro</i> and <i>In vivo</i>

    Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth <i>In vitro</i> and <i>In vivo</i> per Qinghua Xia, Jennifer Sung, Wasim H. Chowdhury, Chien-Lun Chen, Naseruddin Höti, Shabana Shabbeer, Michael A. Carducci, Ronald Rodríguez

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Serial blood-based analysis of AR-V7 in men with advanced prostate cancer

    Serial blood-based analysis of AR-V7 in men with advanced prostate cancer per Mari Nakazawa, Changxue Lu, Y. Chen, Channing J. Paller, Michael A. Carducci, Mario A. Eisenberger, Jun Luo, Emmanuel S. Antonarakis

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    When Using Patient-Reported Outcomes in Clinical Practice, the Measure Matters: A Randomized Controlled Trial

    When Using Patient-Reported Outcomes in Clinical Practice, the Measure Matters: A Randomized Controlled Trial per Claire Snyder, Joseph M. Herman, S.M. White, Brandon Luber, Amanda L. Blackford, Michael A. Carducci, Albert W. Wu

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: